MedPath

Tigan

Tigan 100 mg/mL Injection 2 mL Single Dose Vial

Approved
Approval ID

147def93-cd3d-4e42-89ad-6a6b413bf362

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 14, 2023

Manufacturers
FDA

Henry Schein, Inc

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Trimethobenzamide Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9964
Application NumberNDA017530
Product Classification
M
Marketing Category
C73594
G
Generic Name
Trimethobenzamide Hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateNovember 14, 2023
FDA Product Classification

INGREDIENTS (3)

Trimethobenzamide HydrochlorideActive
Quantity: 100 mg in 1 mL
Code: WDQ5P1SX7Q
Classification: ACTIB
SODIUM CITRATEInactive
Quantity: 0.5 mg in 1 mL
Code: 1Q73Q2JULR
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Quantity: 0.2 mg in 1 mL
Code: 2968PHW8QP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.